Recognition of the American Society of Clinical Oncology (ASCO) of the Liver Protective Effect of Can-Fite’s anti-Cancer Drug Namodenoson

of losses and needs for additional capital to fund our operations and our inability to obtain additional capital on acceptable terms, or at